31st Annual Scientific Meeting of
International Society of Cardiovascular Pharmacotherapy
275D
12H
17M
3S

CALL FOR ABSTRACTS

Please create an account on your first login


The ISCP 2026 Organising Committee warmly invites researchers to submit their abstracts for an opportunity to showcase their work.

All submissions will undergo reviews by the Abstract Selection Committee, who will then determine the final mode of presentation.

How to submit abstracts

Step 1
Register & Submit Abstracts by

1 Apr 2026

Registrants need not pay registration fee at this stage.
An invoice can be generated for payment at a later date.

Step 2
Receive Abstract Submission Acknowledgement email

Step 3
Receive Acceptance Notice by

21 Apr 2026

Step 4
Complete payment on or before

5 May 2026

Themes

For review purposes, abstracts are required to be categorised into different themes as follows:

  • ⁠Arrhythmias, Electrophysiology & Anticoagulation
    This theme focuses on drug therapies for cardiac rhythm disorders, including antiarrhythmic medications and anticoagulants. It covers pharmacological management of various arrhythmias, drug-based approaches in electrophysiology, and anticoagulation strategies for arrhythmia-related complications.

  • Cardiometabolic Health, Lifestyle Medicine & Preventive Cardiology
    This domain addresses pharmacological interventions at the intersection of cardiovascular health and metabolic disorders. It includes drug therapies for obesity, diabetes, hypertension, and lipid management in the context of cardiovascular risk reduction and prevention.

  • Cardiovascular Basic & Translational Science
    This domain focuses on fundamental research in cardiovascular pharmacology and the translation of pharmacological discoveries into clinical applications. It includes studies on drug mechanisms, pharmacokinetics, pharmacodynamics, and early-phase clinical trials of novel cardiovascular medications.

  • Coronary Artery Disease: Acute & Chronic Management
    This theme covers pharmacological approaches in the diagnosis, treatment, and long-term care of patients with coronary artery disease. It includes drug therapies for acute coronary syndromes and chronic conditions, focusing on antiplatelet agents, anticoagulants, statins, beta-blockers, and other cardiovascular medications.

  • Heart Failure, Structural Heart Disease & Pulmonary Vascular Disorders
    This domain encompasses pharmacological management of heart failure, structural heart abnormalities, and pulmonary vascular diseases. It includes topics such as diuretics, ACE inhibitors, ARBs, beta-blockers, and novel drug therapies for these conditions.

  • Special Populations & Multidisciplinary Cardiovascular Care
    This theme covers tailored pharmacological approaches for specific patient groups (e.g., elderly, pediatric) and the integration of cardiovascular pharmacotherapy with other medical specialties. It emphasizes personalized medication strategies and collaborative care models.

Abstract Structure

1. Title: The title should indicate the abstract content. Company or trade names, special symbols, characters, and uncommon abbreviations are not permitted.

2. Type: You may select one of the following types of abstract:

  • Poster Presentation
  • Moderated Poster Presentation
  • Oral Presentation
  • Case Submission Abstract

3. Content: Abstract body should not exceed 250 words. Content must be organized in the following structure:

  • "Objectives", "Materials and Methods", "Results", and "Conclusion"

A sample abstract can be viewed here.


b) Case Submission Abstract

  • Section headings: "Case Background / History", "Problem / Complication", "Results", and "Conclusion"

A sample abstract can be viewed here.

4. Supporting Image/Graph/Illustration (Optional):
You may submit a supporting image, graph, or illustration for your abstract.

Award Categories

Selected abstracts will be nominated for Oral Presentation, Case Presentation, or the Moderated Poster Competition.

Abstract Submission Terms & Conditions

  • All abstracts must be submitted in English.
  • Only online submissions are accepted.
  • Abstracts should contain original material not published or presented internationally.
  • Presenting authors must register for the congress.
  • Ensure all co-authors are listed prior to submission. No additions will be allowed afterward.
banner